Keidy Ventura, 17, receives first dose of Pfizer COVID-19 vaccine in Western New York, NJ Pfizer has asked federal regulators to expand eligibility for booster vaccinations to people aged 16 to 17 years old.
Seth Wenig / AP
hide captions
switch captions
Seth Wenig / AP
Keidy Ventura, 17, receives first dose of Pfizer COVID-19 vaccine in Western New York, NJ Pfizer has asked federal regulators to expand eligibility for booster vaccinations to people aged 16 to 17 years old.
Seth Wenig / AP
For the first time, people under 18 may soon be eligible for a COVID-19 booster shot in the US
On Tuesday, Pfizer CEO and President Albert Bourla said the vaccine maker had submitted its request to the U.S. Food and Drug Administration for an expanded license for use. Emergency booster dose of Pfizer-BioNTech COVID-19 vaccine covers 16- and 17-year-olds.
Bourla did Announcement on Twitter, says “we hope to provide robust protection to as many people as possible, especially for the new variant” – reference to omicron, undetected in the US
Currently, only people 18 years of age or older are eligible for a COVID-19 booster shot in the United States and at least six months after receiving a second dose of Pfizer or Moderna vaccine. Adults 18 years of age and older who have had the Johnson & Johnson vaccine can get a booster shot after two months.
In October, Pfizer and BioNTech publish the result of a randomized study of 10,000 people 16 years of age and older found that the booster dose “restored the high level of vaccine protection against COVID-19 achieved after the second dose,” according to the release. press from companies.
Pfizer’s effort to expand eligibility for booster shots to some adults under the age of 18 comes as top federal health officials are urging all eligible Americans to get the shot. booster drug.
